Hookipa Pharma Files Petition to Validate Stockholder Actions at Annual Meetings

Hookipa Pharma Inc. recently filed a petition seeking validation for certain actions taken by the company’s stockholders at its 2022 and 2023 Annual Meetings. The petition, presented as a Section 205 Proceeding in the Delaware Court of Chancery, aims to address the fixing of record dates that deviated from the requirements of the Delaware General […]

Leave a Reply

Your email address will not be published.

Previous post Orca Energy Group Inc. (OTCMKTS:ORXGF) Short Interest Up 84.2% in January
Next post China Universal Asset Management Co. Ltd. Has $2.71 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD)